A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

RECRUITING

Shengjing Hospital Affiliated to China Medical University, Shenyang

RECRUITING

Harbin first hospital, Harbin

RECRUITING

The Second Affiliated Hospital of Harbin Medical University, Harbin

RECRUITING

Shanghai Tongren Hospital, Shanghai

RECRUITING

Jiangsu Provincial People's Hospital, Nanjing

RECRUITING

The Second Affiliated Hospital of Soochow University, Suzhou

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Affiliated Hospital of Xuzhou Medical University, Xuzhou

RECRUITING

Anqing Municipal Hospital, Anqing

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Tai 'an Central Hospital, Tai’an

RECRUITING

Linyi people's hospital, Linyi

RECRUITING

Tianjin Cancer Hospital, Tianjin

RECRUITING

The First Affiliated Hospital of Ningbo University, Ningbo

RECRUITING

Jiangxi Cancer Hospital, Nanchang

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Peace Hospital Affiliated to Changzhi Medical College, Changzhi

RECRUITING

Sun Yat-Sen University Cancer Canter, Guangzhou

RECRUITING

Mianyang Central Hospital, Mianyang

RECRUITING

Yibin Second People's Hospital, Yibin

RECRUITING

Affiliated hospital of southwest medical university, Luzhou

RECRUITING

Gansu province Wuwei tumour hospital, Wuwei

RECRUITING

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

RECRUITING

Affiliated Hospital of Chengde Medical College, Chengde